JP2017511377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511377A5 JP2017511377A5 JP2017501145A JP2017501145A JP2017511377A5 JP 2017511377 A5 JP2017511377 A5 JP 2017511377A5 JP 2017501145 A JP2017501145 A JP 2017501145A JP 2017501145 A JP2017501145 A JP 2017501145A JP 2017511377 A5 JP2017511377 A5 JP 2017511377A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- disease
- compounds
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461968595P | 2014-03-21 | 2014-03-21 | |
| US61/968,595 | 2014-03-21 | ||
| PCT/US2015/022058 WO2015143447A2 (en) | 2014-03-21 | 2015-03-23 | Methods for treating neurological disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019012873A Division JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511377A JP2017511377A (ja) | 2017-04-20 |
| JP2017511377A5 true JP2017511377A5 (enExample) | 2018-03-29 |
| JP6588962B2 JP6588962B2 (ja) | 2019-10-09 |
Family
ID=54145492
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501145A Active JP6588962B2 (ja) | 2014-03-21 | 2015-03-23 | 神経疾患を治療するための方法 |
| JP2019012873A Withdrawn JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
| JP2020066670A Withdrawn JP2020109123A (ja) | 2014-03-21 | 2020-04-02 | 神経疾患を治療するための方法 |
| JP2022131705A Pending JP2022159555A (ja) | 2014-03-21 | 2022-08-22 | 神経疾患を治療するための方法 |
| JP2024205572A Pending JP2025022992A (ja) | 2014-03-21 | 2024-11-26 | 神経疾患を治療するための方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019012873A Withdrawn JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
| JP2020066670A Withdrawn JP2020109123A (ja) | 2014-03-21 | 2020-04-02 | 神経疾患を治療するための方法 |
| JP2022131705A Pending JP2022159555A (ja) | 2014-03-21 | 2022-08-22 | 神経疾患を治療するための方法 |
| JP2024205572A Pending JP2025022992A (ja) | 2014-03-21 | 2024-11-26 | 神経疾患を治療するための方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10471029B2 (enExample) |
| EP (2) | EP3119911B1 (enExample) |
| JP (5) | JP6588962B2 (enExample) |
| KR (2) | KR102448386B1 (enExample) |
| CN (1) | CN106170563A (enExample) |
| AU (1) | AU2015230972B2 (enExample) |
| CA (1) | CA2941415A1 (enExample) |
| DK (1) | DK3119911T3 (enExample) |
| ES (1) | ES2960625T3 (enExample) |
| FI (1) | FI3119911T3 (enExample) |
| HR (1) | HRP20231172T1 (enExample) |
| HU (1) | HUE063369T2 (enExample) |
| LT (1) | LT3119911T (enExample) |
| PL (1) | PL3119911T3 (enExample) |
| PT (1) | PT3119911T (enExample) |
| RS (1) | RS64744B1 (enExample) |
| SI (1) | SI3119911T1 (enExample) |
| SM (1) | SMT202300369T1 (enExample) |
| WO (1) | WO2015143447A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202300250T1 (it) * | 2015-09-10 | 2023-09-06 | Alzheon Inc | Trattamento della malattia di alzheimer in una particolare popolazione di pazienti |
| WO2018012596A1 (ja) * | 2016-07-13 | 2018-01-18 | 株式会社マイトス | 水素を有効成分として含む軽度認知障害又は認知症の予防又は治療用組成物 |
| CN114805211B (zh) | 2017-03-21 | 2024-08-23 | 润佳（苏州）医药科技有限公司 | 同位素富集3-氨基-1-丙磺酸衍生物、药物组合物及其用途 |
| CN110003058B (zh) | 2018-01-04 | 2022-01-25 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途 |
| CN110668980A (zh) * | 2018-07-03 | 2020-01-10 | 浙江京新药业股份有限公司 | 一种2-取代的高牛磺酸衍生物 |
| PL3829563T3 (pl) * | 2018-08-01 | 2025-04-07 | Alzheon, Inc. | Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnych |
| CA3108182A1 (en) * | 2018-08-01 | 2020-02-06 | Alzheon, Inc. | Sulfopropanoic acid derivatives for treating neurodegenerative disorders |
| CN111170901A (zh) * | 2018-11-13 | 2020-05-19 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途 |
| UA129160C2 (uk) * | 2019-06-17 | 2025-01-29 | Алзхеон, Інк. | Спосіб лікування хвороби альцгеймера |
| CN112791078B (zh) | 2019-11-13 | 2022-12-06 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸及其衍生物的用途 |
| WO2023212289A1 (en) | 2022-04-28 | 2023-11-02 | Alzheon, Inc. | Tramiprosate for treating apoe4-related diseases |
| JP2025539186A (ja) | 2022-12-02 | 2025-12-03 | アルツェオン・インコーポレーテッド | トラミプロセートを用いて神経変性障害を治療する方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| EP0625212B1 (en) * | 1992-10-13 | 2004-03-24 | Duke University | Methods of detecting alzheimer's disease |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20060079578A1 (en) * | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| WO2005060393A2 (en) | 2003-08-11 | 2005-07-07 | California Institute Of Technology | Microfluidic large scale integration |
| CA2830727C (en) | 2006-10-12 | 2016-11-29 | Bhi Limited Partnership | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| EP2102165A2 (en) | 2006-11-24 | 2009-09-23 | AC Immune S.A. | N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| WO2012006329A2 (en) * | 2010-07-06 | 2012-01-12 | Genomind, Llc | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| CA2808630A1 (en) | 2010-08-19 | 2012-02-23 | Buck Institute For Age Research | Methods of treating mild cognitive impairment (mci) and related disorders |
| EP2994160B1 (en) | 2013-05-06 | 2019-07-03 | Baxalta Incorporated | Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g |
| AU2015214058B2 (en) * | 2014-02-08 | 2020-07-09 | Genentech, Inc. | Methods of treating Alzheimer's Disease |
| SMT202300250T1 (it) | 2015-09-10 | 2023-09-06 | Alzheon Inc | Trattamento della malattia di alzheimer in una particolare popolazione di pazienti |
| US20180250249A1 (en) | 2016-02-02 | 2018-09-06 | Alzheon, Inc. | Methods of treating neurodegenerative disorders in a particular population |
-
2015
- 2015-03-23 WO PCT/US2015/022058 patent/WO2015143447A2/en not_active Ceased
- 2015-03-23 KR KR1020167027090A patent/KR102448386B1/ko active Active
- 2015-03-23 KR KR1020227033161A patent/KR102645633B1/ko active Active
- 2015-03-23 RS RS20230993A patent/RS64744B1/sr unknown
- 2015-03-23 US US15/127,565 patent/US10471029B2/en active Active
- 2015-03-23 EP EP15764560.7A patent/EP3119911B1/en active Active
- 2015-03-23 FI FIEP15764560.7T patent/FI3119911T3/fi active
- 2015-03-23 AU AU2015230972A patent/AU2015230972B2/en active Active
- 2015-03-23 EP EP23189240.7A patent/EP4289820A3/en active Pending
- 2015-03-23 SI SI201531967T patent/SI3119911T1/sl unknown
- 2015-03-23 JP JP2017501145A patent/JP6588962B2/ja active Active
- 2015-03-23 CA CA2941415A patent/CA2941415A1/en active Pending
- 2015-03-23 HU HUE15764560A patent/HUE063369T2/hu unknown
- 2015-03-23 PT PT157645607T patent/PT3119911T/pt unknown
- 2015-03-23 SM SM20230369T patent/SMT202300369T1/it unknown
- 2015-03-23 HR HRP20231172TT patent/HRP20231172T1/hr unknown
- 2015-03-23 LT LTEPPCT/US2015/022058T patent/LT3119911T/lt unknown
- 2015-03-23 ES ES15764560T patent/ES2960625T3/es active Active
- 2015-03-23 DK DK15764560.7T patent/DK3119911T3/da active
- 2015-03-23 CN CN201580015086.8A patent/CN106170563A/zh active Pending
- 2015-03-23 PL PL15764560.7T patent/PL3119911T3/pl unknown
-
2019
- 2019-01-29 JP JP2019012873A patent/JP2019065044A/ja not_active Withdrawn
- 2019-09-13 US US16/570,487 patent/US20200101031A1/en not_active Abandoned
-
2020
- 2020-04-02 JP JP2020066670A patent/JP2020109123A/ja not_active Withdrawn
-
2022
- 2022-07-29 US US17/877,380 patent/US20230087041A1/en active Pending
- 2022-08-22 JP JP2022131705A patent/JP2022159555A/ja active Pending
-
2024
- 2024-11-26 JP JP2024205572A patent/JP2025022992A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017511377A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| CY1119880T1 (el) | Παραγωγα πυρρολοπυριμιδινης για χρηση στη θεραπεια ιικων λοιμωξεων | |
| JP2016521119A5 (enExample) | ||
| JP2015024998A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2012504133A5 (enExample) | ||
| JP2017520613A5 (enExample) | ||
| JP2017528503A5 (enExample) | ||
| JP2016518328A5 (enExample) | ||
| JP2013507415A5 (enExample) | ||
| JP2016539134A5 (enExample) | ||
| JP2017075173A5 (enExample) | ||
| JP2015508103A5 (enExample) | ||
| JP2018529698A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| FI3119911T3 (fi) | Yhdisteitä käytettäväksi alzheimerin taudin hoitamisessa apoe4+/+-potilaissa | |
| JP2016522254A5 (enExample) | ||
| JP2019529514A5 (enExample) | ||
| JP2016530265A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2010521516A5 (enExample) | ||
| JP2016539157A5 (enExample) | ||
| JP2018530608A5 (enExample) |